Difference between revisions of "Template:Glutamate receptor modulators"
Jump to navigation
Jump to search
imported>Ronhjones m (subst:'ing, replaced: {{•}} → • (236) using AWB) |
imported>Anypodetos m (Simplify markup, replaced: • → • (236), <br> → <br /> using AWB) |
||
| Line 10: | Line 10: | ||
| group1 = [[AMPA receptor|AMPA]] | | group1 = [[AMPA receptor|AMPA]] | ||
| − | | list1 = '''[[Ampakine|Agonists]]:''' [[5-Fluorowillardiine]]& | + | | list1 = '''[[Ampakine|Agonists]]:''' [[5-Fluorowillardiine]] • [[AMPA]] • [[Domoic acid]] • [[Quisqualic acid]]; ''[[Positive allosteric modulator]]s:'' [[Aniracetam]] • [[Cyclothiazide]] • [[CX-516]] • [[CX-546]] • [[CX-614]] • [[CX-691]] • [[CX-717]] • [[Diazoxide]] • [[Hydrochlorothiazide|HCTZ]] • [[IDRA-21]] • [[LY-392,098]] • [[LY-404,187]] • [[LY-451,395]] • [[LY-451,646]] • [[LY-503,430]] • [[Oxiracetam]] • [[PEPA (drug)|PEPA]] • [[Piracetam]] • [[Pramiracetam]] • [[S-18986]] • [[Sunifiram]] • [[Unifiram]]<br/>'''Antagonists:''' [[ATPO]] • [[Barbiturates]] • [[Caroverine]] • [[CNQX]] • [[DNQX]] • [[GYKI-52466]] • [[NBQX]] • [[Perampanel]] • [[Talampanel]] • [[Tezampanel]] • [[Topiramate]]; ''[[Negative allosteric modulator]]s:'' [[GYKI-53,655]] |
| group2 = [[NMDA receptor|NMDA]] | | group2 = [[NMDA receptor|NMDA]] | ||
| − | | list2 = '''Agonists:''' ''Glutamate/acite site competitive agonists'': [[Aspartate]]& | + | | list2 = '''Agonists:''' ''Glutamate/acite site competitive agonists'': [[Aspartate]] • [[Glutamate]] • [[Homoquinolinic acid]] • [[Ibotenic acid]] • [[NMDA]] • [[Quinolinic acid]] • [[Tetrazolylglycine]]; ''Glycine site agonists:'' [[ACBD (drug)|ACBD]] • [[ACPC]] • [[ACPD]] • [[Alanine]] • [[Carboxycyclopropylglycine|CCG]] • [[Cycloserine]] • [[N-(3,3-Diphenylpropyl)glycinamide|DHPG]] • [[Fluoroalanine]] • [[Glycine]] • [[HA-966]] • [[L-687,414]] • [[Milacemide]] • [[Sarcosine]] • [[Serine]] • [[Tetrazolylglycine]]; ''Polyamine site agonists:'' [[Acamprosate]] • [[Spermidine]] • [[Spermine]]<br/>'''[[NMDA receptor antagonist|Antagonists]]:''' ''Competitive antagonists:'' [[AP5|AP5 (APV)]] • [[AP-7 (drug)|AP7]] • [[CGP-37849]] • [[CGP-39551]] • [[CGP-39653]] • [[CGP-40116]] • [[CGS-19755]] • [[3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid|CPP]] • [[LY-233,053]] • [[LY-235,959]] • [[LY-274,614]] • [[MDL-100,453]] • [[Midafotel|Midafotel (d-CPPene)]] • [[NPC-12,626]] • [[NPC-17,742]] • [[PBPD]] • [[PEAQX]] • [[Perzinfotel]] • [[cis-1-(phenanthrene-2-carbonyl)piperazine-2,3-dicarboxylic acid|PPDA]] • [[SDZ-220581]] • [[Selfotel]]; ''Noncompetitive antagonists:'' [[ARR-15,896]] • [[Caroverine]] • [[Dexanabinol]] • [[FPL-12495]] • [[FR-115,427]] • [[Hodgkinsine]] • [[Magnesium]] • [[MDL-27,266]] • [[NPS-1506]] • [[Psychotridine]] • [[Zinc]]; ''Uncompetitive pore blockers:'' [[2-MDP]] • [[3-MeO-PCP]] • [[8a-Phenyldecahydroquinoline|8A-PDHQ]] • [[Amantadine]] • [[Aptiganel]] • [[ARL-12,495]] • [[ARL-15,896-AR]] • [[ARL-16,247]] • [[Budipine]] • [[Delucemine]] • [[Dexoxadrol]] • [[Dextrallorphan]] • [[Dieticyclidine]] • [[Dizocilpine]] • [[Endopsychosin]] • [[Esketamine]] • [[Etoxadrol]] • [[Eticyclidine]] • [[Gacyclidine]] • [[Ibogaine]] • [[Indantadol]] • [[Ketamine]] • [[Ketobemidone]] • [[Loperamide]] • [[Memantine]] • [[Meperidine|Meperidine (Pethidine)]] • [[Methadone]] • [[Methorphan]] ([[Dextromethorphan]], [[Levomethorphan]]) • [[Methoxetamine]] • [[Milnacipran]] • [[Morphanol]] ([[Dextrorphan]], [[Levorphanol]]) • [[NEFA (drug)|NEFA]] • [[Neramexane]] • [[Nitrous oxide]] • [[Noribogaine]] • [[Orphenadrine]] • [[PCPr]] • [[Phencyclamine]] • [[Phencyclidine]] • [[Propoxyphene]] • [[Remacemide]] • [[Rhynchophylline]] • [[Riluzole]] • [[Rimantadine]] • [[Rolicyclidine]] • [[Sabeluzole]] • [[Tenocyclidine]] • [[Tiletamine]] • [[Tramadol]] • [[Xenon]]; ''Glycine site antagonists:'' [[ACEA-1021]] • [[ACEA-1328]] • [[1-Aminocyclopropanecarboxylic acid|ACPC]] • [[Carisoprodol]] • [[CGP-39653]] • [[7-Chlorokynurenate|CKA]] • [[DCKA]] • [[Felbamate]] • [[Gavestinel]] • [[GV-196,771]] • [[Kynurenic acid]] • [[L-689,560]] • [[L-701,324]] • [[Lacosamide]] • [[Licostinel]] • [[LU-73,068]] • [[MDL-105,519]] • [[Meprobamate]] • [[MRZ 2/576]] • [[PNQX]] • [[ZD-9379]]; ''NR2B subunit antagonists:'' [[Besonprodil]] • [[CO-101,244|CO-101,244 (PD-174,494)]] • [[CP-101,606]] • [[Eliprodil]] • [[Haloperidol]] • [[Ifenprodil]] • [[Isoxsuprine]] • [[Nylidrin]] • [[Ro8-4304]] • [[Ro25-6981]] • [[Traxoprodil]]; ''Polyamine site antagonists:'' [[Arcaine]] • [[Co 101676]] • [[1,3-Diaminopropane|Diaminopropane]] • [[Diethylenetriamine]] • [[Huperzine A]] • [[Putrescine]] • [[Ro 25-6981]]; ''Unclassified/unsorted antagonists:'' [[Chloroform]] • [[Diethyl ether]] • [[Enflurane]] • [[Ethanol|Ethanol (Alcohol)]] • [[Halothane]] • [[Isoflurane]] • [[Methoxyflurane]] • [[Toluene]] • [[1,1,1-Trichloroethane|Trichloroethane]] • [[2,2,2-Trichloroethanol|Trichloroethanol]] • [[Trichloroethylene]] • [[Xylene]] |
| group3 = [[Kainate receptor|Kainate]] | | group3 = [[Kainate receptor|Kainate]] | ||
| − | | list3 = '''Agonists:''' [[5-Iodowillardiine]]& | + | | list3 = '''Agonists:''' [[5-Iodowillardiine]] • [[ATPA]] • [[Domoic acid]] • [[Kainic acid]] • [[LY-339,434]] • [[SYM-2081]]<br/>'''Antagonists:''' [[CNQX]] • [[DNQX]] • [[LY-382,884]] • [[NBQX]] • [[NS102]] • [[Tezampanel]] • [[Topiramate]] • [[UBP-302]]; ''Negative allosteric modulators:'' [[NS-3763]] |
}} | }} | ||
| Line 25: | Line 25: | ||
| group1 = [[Metabotropic_glutamate_receptor#Group_I|Group I]] | | group1 = [[Metabotropic_glutamate_receptor#Group_I|Group I]] | ||
| − | | list1 = '''Agonists:''' ''Unselective:'' [[ACPD]]& | + | | list1 = '''Agonists:''' ''Unselective:'' [[ACPD]] • [[Dihydroxyphenylglycine|DHPG]] • [[Quisqualic acid]]; ''mGlu1-selective:'' [[Ro01-6128]] • [[Ro67-4853]] • [[Ro67-7476]] • [[VU-71]]; ''mGlu5-selective:'' [[ADX-47273]] • [[CDPPB]] • [[CHPG]] • [[1-(3-fluorophenyl)-N-((3-fluorophenyl)methylideneamino)methanimine|DFB]] • [[VU-1545]]<br/>'''Antagonists:''' ''Unselective:'' [[MCPG]] • [[NPS-2390]]; ''mGlu1-selective:'' [[BAY 36-7620]] • [[CPCCOEt]] • [[LY-367,385]] • [[LY-456,236]]; ''mGlu5-selective:'' [[DMeOB]] • [[Fenobam]] • [[LY-344,545]] • [[2-Methyl-6-(phenylethynyl)pyridine|MPEP]] • [[MTEP]] • [[SIB-1757]] • [[SIB-1893]] |
| group2 = [[Metabotropic_glutamate_receptor#Group_II_.26_Group_III|Group II]] | | group2 = [[Metabotropic_glutamate_receptor#Group_II_.26_Group_III|Group II]] | ||
| − | | list2 = '''Agonists:''' ''Unselective:'' [[CBiPES]]& | + | | list2 = '''Agonists:''' ''Unselective:'' [[CBiPES]] • [[DCG-IV]] • [[Eglumegad]] • [[LY-379,268]] • [[LY-404,039]] • [[LY-487,379]] • [[MGS-0028]]; ''mGlu2-selective:'' [[Biphenylindanone A|BINA]] • [[LY-566,332]]<br/>'''Antagonists:''' ''Unselective:'' [[APICA (drug)|APICA]] • [[EGLU]] • [[HYDIA]] • [[LY-307,452]] • [[LY-341,495]] • [[MCPG]] • [[MGS-0039]]: ''mGlu2-selective:'' [[PCCG-4]]; ''mGlu3-selective:'' [[CECXG]] |
| group3 = [[Metabotropic_glutamate_receptor#Group_II_.26_Group_III|Group III]] | | group3 = [[Metabotropic_glutamate_receptor#Group_II_.26_Group_III|Group III]] | ||
| − | | list3 = '''Agonists:''' ''Unselective:'' [[L-AP4]]; ''mGlu4-selective:'' [[PHCCC]]& | + | | list3 = '''Agonists:''' ''Unselective:'' [[L-AP4]]; ''mGlu4-selective:'' [[PHCCC]] • [[VU-001,171]] • [[VU-0155,041]]; ''mGlu7-selective:'' [[AMN082]]; ''mGlu8-selective:'' [[DCPG]]<br/>'''Antagonists:''' ''Unselective:'' [[CPPG]] • [[MAP4 (drug)|MAP4]] • [[MSOP (drug)|MSOP]] • [[MPPG]] • [[MTPG]] • [[UBP-1112]]; ''mGlu7-selective:'' [[MMPIP]] |
}} | }} | ||
| − | | group3 = [[Glutamate transporter|Transporter]]<br>[[Reuptake inhibitor|inhibitor]]s | + | | group3 = [[Glutamate transporter|Transporter]]<br />[[Reuptake inhibitor|inhibitor]]s |
| list3 = {{Navbox subgroup | | list3 = {{Navbox subgroup | ||
| groupstyle = background: LightYellow | | groupstyle = background: LightYellow | ||
| group1 = [[Glutamate transporter|EAAT]]s | | group1 = [[Glutamate transporter|EAAT]]s | ||
| − | | list1 = [[Dihydrokainic acid|DHKA]]& | + | | list1 = [[Dihydrokainic acid|DHKA]] • [[L-trans-Pyrrolidine-2,4-dicarboxylic acid|PDC]] • [[WAY-213,613]] |
| group2 = [[Vesicular glutamate transporters|vGluTs]] | | group2 = [[Vesicular glutamate transporters|vGluTs]] | ||
| − | | list2 = [[7-Chlorokynurenic acid|7-CKA]]& | + | | list2 = [[7-Chlorokynurenic acid|7-CKA]] • [[Evans blue]] |
}} | }} | ||